What is KYBELLA?
It is a prescription medicine used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called “double chin.” KYBELLA (deoxycholic acid) is the first and only FDA-approved double chin injection treatment that is used in adults to improve the appearance and profile of moderate to severe fat below the chin. It is not known if Kybella treatments are safe and effective in children less than 18 years of age. It is not known if it is safe and effective for use outside of the submental area.
How Does KYBELLA work?
The active ingredient in our Omaha Kybella double chin injection treatment is deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into the fat beneath your chin, it causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat.
Is KYBELLA right for me?
Only you and your Omaha Kybella treatment doctor can decide if it is right for you. If you’re bothered by submental fullness, or double chin, contact us to set up your treatment.
How many people have been treated with KYBELLA?
KYBELLA has been the focus of a global clinical development program involving over 20 clinical studies with more than 2,600 patients worldwide, of which over 1,600 have been treated with it.
Will I experience any side effects?
The safety profile of KYBELLA is well characterized. The most common side effects are swelling, bruising, pain, numbness, redness and areas of hardness around the treatment area. It can cause serious side effects, including trouble swallowing and nerve injury in the jaw that can cause an uneven smile or facial muscle weakness. These are not all of the possible side effects of it. Contact us for medical advice about side effects.
How many treatments will I need?
You and your doctor will customize your Omaha Kybella treatment regimen, including how many double chin injection treatments you need, based on your desired chin profile. Many patients experience visible results in 2 to 4 treatment sessions. During these sessions, your HCP will administer KYBELLA into the fat under your chin using multiple injections. Up to 6 treatment sessions may be administered spaced no less than one month apart.
- In clinical studies, results for KYBELLA-treated patients who had a ≥1-grade composite improvement were 8% (1 treatment), 28% (2 treatments), 43% (3 treatments), 55% (4 treatments), 66% (5 treatments) and 72% (6 treatments)
- In clinical studies, results for KYBELLA-treated patients who had a ≥2-grade composite improvement were 0% (1 treatment), .2% (2 treatments), .8% (3 treatments), 3.5% (4 treatments), 3.9% (5 treatments) and 15% (6 treatments)
59% of subjects in the clinical trials received all 6 treatments
How long will the results last
When injected into the fat under your chin, KYBELLA causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. After the aesthetic response is achieved, retreatment is not expected.
What To Expect
You and your doctor will design a treatment plan tailored to help you improve your chin profile. During your treatment sessions, your HCP will administer KYBELLA into the fat under your chin using multiple injections. Many patients experience visible results in 2 to 4 treatment sessions. Up to 6 treatment sessions may be administered spaced no less than one month apart.
Clinical Trial Results for KYBELLA-Treated Patients
| After 1 Treatment | After 2 Treatments | After 3 Treatments | After 4 Treatments | After 5 Treatments | After 6 Treatments | |
| Percentage of patients who experienced at least a 1-grade composite improvement | 8% | 28% | 43% | 55% | 66% | 72% |
| Percentage of patients who experienced at least a 2-grade composite improvement | 0% | .2% | .8% | 3.5% | 3.9% | 15% |
KYBELLA has been the focus of a global clinical development program involving over 20 clinical studies with more than 2,600 patients worldwide, of which over 1,600 have been treated with it.
In the pivotal Phase III clinical trials:
- 68.2% of patients experienced a ≥1-grade improvement with KYBELLA, compared to 20.5% of patients who responded to placebo, based on validated physician and patient measurements
- 16% of patients experienced a ≥2-grade improvement with KYBELLA, compared to 2% of patients who responded to placebo, based on validated physician and patient measurements
- 79% of patients treated reported satisfaction with the appearance of their face and chin
- After being treated, patients reported improvement in self-perception, including feeling happier and younger based on their chin profile, as well as feeling less embarrassed, less self-conscious, less overweight and less bothered by submental fullness
- KYBELLA can cause serious side effects, including trouble swallowing or nerve injury in the jaw that can cause an uneven smile or facial muscle weakness. The most common side effects include: swelling, bruising, pain, numbness, redness and areas of hardness in the treatment area